10.16
Schlusskurs vom Vortag:
$10.55
Offen:
$10.67
24-Stunden-Volumen:
74,731
Relative Volume:
0.39
Marktkapitalisierung:
$133.63M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00288
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+8.78%
1M Leistung:
+13.27%
6M Leistung:
+47.25%
1J Leistung:
+35.11%
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AVTX
Avalo Therapeutics Inc
|
10.16 | 118.63M | 1.93M | -7.96M | -36.78M | -3,530.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
2025-03-25 | Eingeleitet | Jefferies | Buy |
2025-03-25 | Eingeleitet | Stifel | Buy |
2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
2025-02-21 | Eingeleitet | Wedbush | Outperform |
2024-12-19 | Eingeleitet | BTIG Research | Buy |
2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
Historical volatility pattern of Avalo Therapeutics Inc. visualizedTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Analyzing recovery setups for Avalo Therapeutics Inc. investors2025 Major Catalysts & Pattern Based Trade Signal System - Newser
How liquid is Avalo Therapeutics Inc. stock2025 Market Trends & Real-Time Buy Signal Notifications - khodrobank.com
What technical models suggest about Avalo Therapeutics Inc.’s comebackDollar Strength & Low Risk Investment Opportunities - Newser
Heatmap analysis for Avalo Therapeutics Inc. and competitorsJobs Report & Momentum Based Trading Signals - Newser
Candlestick signals on Avalo Therapeutics Inc. stock todayTrend Reversal & Fast Exit/Entry Strategy Plans - Newser
Will Avalo Therapeutics Inc. bounce back from current supportMarket Performance Report & AI Powered Market Entry Strategies - Newser
Is Avalo Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
How does Avalo Therapeutics Inc. perform in inflationary periodsTrade Exit Report & Weekly Breakout Stock Alerts - khodrobank.com
Will Avalo Therapeutics Inc. announce a stock split2025 Top Gainers & Free Growth Oriented Trading Recommendations - khodrobank.com
Is Avalo Therapeutics Inc. trending in predictive chart models2025 Growth vs Value & Smart Allocation Stock Reports - Newser
What Technical Tools Say About Avalo Therapeutics Inc. RecoveryQuarterly Performance Summary & Risk Adjusted Buy/Sell Alerts - beatles.ru
Using data models to predict Avalo Therapeutics Inc. stock movementCEO Change & Weekly Market Pulse Updates - Newser
Aug Final Week: Can Avalo Therapeutics Inc. stock double in the next year - khodrobank.com
What are Avalo Therapeutics Inc.’s recent SEC filings showingCEO Change & Weekly High Potential Alerts - khodrobank.com
Will Avalo Therapeutics Inc. benefit from macro trendsJuly 2025 Selloffs & Safe Entry Momentum Tips - Newser
Volatility Watch: Should I buy Avalo Therapeutics Inc. stock nowWeekly Stock Report & Growth Oriented Trade Recommendations - خودرو بانک
How institutional ownership impacts Avalo Therapeutics Inc. stockJuly 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Real time scanner hits for Avalo Therapeutics Inc. explainedTrade Performance Summary & Consistent Income Trade Ideas - Newser
Is Avalo Therapeutics Inc. a speculative investmentJuly 2025 Big Picture & Daily Profit Focused Screening - khodrobank.com
How to read the order book for Avalo Therapeutics Inc.Weekly Earnings Recap & Capital Protection Trading Alerts - Newser
Can Avalo Therapeutics Inc. maintain its current growth rateMarket Performance Report & Daily Stock Trend Watchlist - khodrobank.com
What Technical Tools Say About Avalo Therapeutics Inc. Recovery getLinesFromResByArray error: size == 0 - 더경남뉴스
Will Avalo Therapeutics Inc. outperform during market rallies2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - kpenews.com
Should you hold or exit Avalo Therapeutics Inc. now2025 Market WrapUp & Precise Buy Zone Identification - Newser
Quant Tools Rank Avalo Therapeutics Inc. as High Risk High Reward getLinesFromResByArray error: size == 0 - kangso.co.kr
Custom strategy builders for tracking Avalo Therapeutics Inc.2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Is Avalo Therapeutics Inc. still worth holding after the dip2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
News impact scoring models applied to Avalo Therapeutics Inc.Insider Buying & Real-Time Volume Analysis Alerts - Newser
Avalo Therapeutics Inc. stock outlook for YEARGap Down & Detailed Earnings Play Alerts - Newser
Will Avalo Therapeutics Inc. Sustain Its Chart Breakout getLinesFromResByArray error: size == 0 - newsyoung.net
Can swing trading help recover from Avalo Therapeutics Inc. lossesForecast Cut & Daily Technical Forecast Reports - Newser
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avalo Therapeutics Inc-Aktie (AVTX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Almenoff June Sherie | Director |
Nov 12 '24 |
Buy |
12.50 |
500 |
6,250 |
500 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):